GERN
Price
$1.60
Change
+$0.04 (+2.56%)
Updated
Jun 6 closing price
Capitalization
1.02B
61 days until earnings call
UTHR
Price
$325.45
Change
+$5.74 (+1.80%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
14.7B
54 days until earnings call
Interact to see
Advertisement

GERN vs UTHR

Header iconGERN vs UTHR Comparison
Open Charts GERN vs UTHRBanner chart's image
Geron
Price$1.60
Change+$0.04 (+2.56%)
Volume$9.6M
Capitalization1.02B
United Therapeutics
Price$325.45
Change+$5.74 (+1.80%)
Volume$4.87K
Capitalization14.7B
GERN vs UTHR Comparison Chart
Loading...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GERN vs. UTHR commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GERN is a StrongBuy and UTHR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (GERN: $1.60 vs. UTHR: $325.82)
Brand notoriety: GERN and UTHR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GERN: 73% vs. UTHR: 69%
Market capitalization -- GERN: $1.02B vs. UTHR: $14.7B
GERN [@Biotechnology] is valued at $1.02B. UTHR’s [@Biotechnology] market capitalization is $14.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GERN’s FA Score shows that 0 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • GERN’s FA Score: 0 green, 5 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than GERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GERN’s TA Score shows that 7 TA indicator(s) are bullish while UTHR’s TA Score has 5 bullish TA indicator(s).

  • GERN’s TA Score: 7 bullish, 2 bearish.
  • UTHR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GERN is a better buy in the short-term than UTHR.

Price Growth

GERN (@Biotechnology) experienced а +5.26% price change this week, while UTHR (@Biotechnology) price change was +2.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

GERN is expected to report earnings on Aug 07, 2025.

UTHR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($14.7B) has a higher market cap than GERN($1.02B). UTHR YTD gains are higher at: -9.336 vs. GERN (-54.802). UTHR has higher annual earnings (EBITDA): 1.68B vs. GERN (-114.49M). UTHR has more cash in the bank: 3.32B vs. GERN (397M). GERN has less debt than UTHR: GERN (122M) vs UTHR (200M). UTHR has higher revenues than GERN: UTHR (2.99B) vs GERN (116M).
GERNUTHRGERN / UTHR
Capitalization1.02B14.7B7%
EBITDA-114.49M1.68B-7%
Gain YTD-54.802-9.336587%
P/E RatioN/A12.98-
Revenue116M2.99B4%
Total Cash397M3.32B12%
Total Debt122M200M61%
FUNDAMENTALS RATINGS
GERN vs UTHR: Fundamental Ratings
GERN
UTHR
OUTLOOK RATING
1..100
128
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
9126
SMR RATING
1..100
9445
PRICE GROWTH RATING
1..100
6449
P/E GROWTH RATING
1..100
7357
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UTHR's Valuation (66) in the Pharmaceuticals Other industry is in the same range as GERN (92) in the Biotechnology industry. This means that UTHR’s stock grew similarly to GERN’s over the last 12 months.

UTHR's Profit vs Risk Rating (26) in the Pharmaceuticals Other industry is somewhat better than the same rating for GERN (91) in the Biotechnology industry. This means that UTHR’s stock grew somewhat faster than GERN’s over the last 12 months.

UTHR's SMR Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for GERN (94) in the Biotechnology industry. This means that UTHR’s stock grew somewhat faster than GERN’s over the last 12 months.

UTHR's Price Growth Rating (49) in the Pharmaceuticals Other industry is in the same range as GERN (64) in the Biotechnology industry. This means that UTHR’s stock grew similarly to GERN’s over the last 12 months.

UTHR's P/E Growth Rating (57) in the Pharmaceuticals Other industry is in the same range as GERN (73) in the Biotechnology industry. This means that UTHR’s stock grew similarly to GERN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GERNUTHR
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
53%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 2 days ago
61%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 9 days ago
69%
Declines
ODDS (%)
Bearish Trend 24 days ago
76%
Bearish Trend 2 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 2 days ago
61%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
ETC.X16.333082-0.946209
-5.48%
Ethereum Classic cryptocurrency
CVP.X0.008262-0.000507
-5.78%
PowerPool cryptocurrency
IOTX.X0.020466-0.001260
-5.80%
IoTeX cryptocurrency
CELR.X0.007991-0.000566
-6.62%
Celer Network cryptocurrency
GHST.X0.366918-0.033014
-8.25%
Aavegotchi cryptocurrency

GERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, GERN has been loosely correlated with SER. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if GERN jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GERN
1D Price
Change %
GERN100%
+2.56%
SER - GERN
66%
Loosely correlated
N/A
LIANY - GERN
53%
Loosely correlated
-1.15%
VCYT - GERN
44%
Loosely correlated
+1.78%
DAWN - GERN
40%
Loosely correlated
+3.45%
MIRM - GERN
39%
Loosely correlated
+3.87%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with DAWN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-1.26%
DAWN - UTHR
41%
Loosely correlated
+0.29%
VKTX - UTHR
35%
Loosely correlated
+0.15%
GERN - UTHR
35%
Loosely correlated
+0.97%
ROIV - UTHR
34%
Loosely correlated
-0.18%
TECH - UTHR
34%
Loosely correlated
-3.15%
More